Life Sciences Tools and Services
Company Overview of Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company also provides services related to drug substances, such as cGMP protein/plasmid DNA production, microbial cell banking, patented protein expression technology, analytics, and regulatory support. In addition, it offers drug product manufacturing services, including formulation, aseptic vial filling, aseptic pre-filled syringe filling, lyophilization, stability and rele...
11040 Roselle Street
San Diego, CA 92121
Founded in 1997
Key Executives for Ajinomoto Althea, Inc.
Vice President of Human Resources
Vice President of Biologics
Compensation as of Fiscal Year 2017.
Ajinomoto Althea, Inc. Key Developments
Althea CMO Presents at Peptalk – The Protein Science Week, Jan-11-2018 03:05 PM
Jan 5 18
Althea CMO Presents at Peptalk – The Protein Science Week, Jan-11-2018 03:05 PM. Venue: San Diego, California, United States. Speakers: Lynette Schroeter, Group Lead, Formulations Development.
Ajinomoto Althea, Inc. to Open GMP Production Suite in Newly Constructed High Potency Products Commercial Manufacturing Facility in San Diego
Sep 19 17
Ajinomoto Althea, Inc. (Althea) announced it will soon open a GMP production suite in its newly constructed High Potency Products (HPP) commercial manufacturing facility located in San Diego, CA. Althea took ownership of the new facility on May 1, 2015 and phased construction and retrofitting commenced in January 2016. Althea is currently offering process development and analytical services to clients from the new facility and will be open for GMP bioconjugation and complex formulation in November 2017. Althea anticipates full manufacturing services including high containment fill and finish will commence in fourth quarter of 2018. The new Althea facility is uniquely designed to develop, manufacture, test, and release HPPs including Antibody Drug Conjugates (ADCs), Highly Potent Active Pharmaceutical Ingredients (HPAPIs), and other complex formulations of highly potent drugs.
Ajinomoto Althea, Inc. Presents at World ADC San Diego, Sep-21-2017 11:00 AM
Sep 18 17
Ajinomoto Althea, Inc. Presents at World ADC San Diego, Sep-21-2017 11:00 AM. Venue: Sheraton San Diego Marina, 1380 Harbor Island Dr, San Diego, California, United States. Speakers: Michael Molony, Director, Analytical Development & QC.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|